[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kalhapure et al., 2015 - Google Patents

Dendrimers–from organic synthesis to pharmaceutical applications: An update

Kalhapure et al., 2015

Document ID
5438723175729126417
Author
Kalhapure R
Kathiravan M
Akamanchi K
Govender T
Publication year
Publication venue
Pharmaceutical Development and Technology

External Links

Snippet

Dendrimers are a relatively new class of monodisperse polymers, which have tree-like spherical structures with well-defined sizes and shapes. Their unique structure has a significant impact on their physical and chemical properties. Research on dendrimers is of …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • A61K47/48884—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes

Similar Documents

Publication Publication Date Title
Kalhapure et al. Dendrimers–from organic synthesis to pharmaceutical applications: An update
Mittal et al. Dendrimers: a new race of pharmaceutical nanocarriers
Lyu et al. Poly (amidoamine) dendrimers: Covalent and supramolecular synthesis
Mandal Dendrimers in targeted drug delivery applications: A review of diseases and cancer
Jain et al. Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability
Abbasi et al. Dendrimers: synthesis, applications, and properties
Sharma et al. Designing dendrimer and miktoarm polymer based multi-tasking nanocarriers for efficient medical therapy
Esfand et al. Poly (amidoamine)(PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Liu et al. Designing dendrimers for drug delivery
Paleos et al. Drug delivery using multifunctional dendrimers and hyperbranched polymers
Medina et al. Dendrimers as carriers for delivery of chemotherapeutic agents
Tomalia et al. Dendrimers, dendrons, and dendritic polymers: discovery, applications, and the future
D'Emanuele et al. Dendrimer–drug interactions
Nanjwade et al. Dendrimers: emerging polymers for drug-delivery systems
Bai et al. Recent progress in dendrimer-based nanocarriers
Baig et al. A review about dendrimers: synthesis, types, characterization and applications
Patel et al. Synthetic strategy of dendrimers: A review
Gupta et al. Dendrimers and its biomedical applications
Klajnert et al. Dendrimers in biomedical applications
Pushkar et al. Dendrimers: Nanotechnology derived novel polymers in drug delivery
Rai et al. Dendrimers: a potential carrier for targeted drug delivery system
Gothwal et al. Toxicity and biocompatibility aspects of dendrimers
Hari et al. Dendrimer: Globular nanostructured materials for drug delivery
Fernandes et al. Supramolecular dendrimers based novel platforms for effective oral delivery of therapeutic moieties
Namazi et al. Fabrication of triblock ABA type peptide dendrimer based on glutamic acid dimethyl ester and PEG as a potential nano drug delivery agent